Gout Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

NLRP3 Inflammasome Activation Among Patients During Acute Gout Flares
Condition:   Gout Arthritis Intervention:   Sponsor:   Centre Hospitalier Saint Joseph Saint Luc de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers With Elevated Uric Acid Levels
Condition:   Gout Interventions:   Drug: PRX-115;   Drug: Placebo Sponsor:   Protalix Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2023 Category: Research Source Type: clinical trials

NLRP3 Inflammasome Activation Among Patients During Acute Gout Flares
Condition:   Gout Arthritis Intervention:   Sponsor:   Centre Hospitalier Saint Joseph Saint Luc de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers With Elevated Uric Acid Levels
Condition:   Gout Interventions:   Drug: PRX-115;   Drug: Placebo Sponsor:   Protalix Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2023 Category: Research Source Type: clinical trials

NLRP3 Inflammasome Activation Among Patients During Acute Gout Flares
Condition:   Gout Arthritis Intervention:   Sponsor:   Centre Hospitalier Saint Joseph Saint Luc de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers With Elevated Uric Acid Levels
Condition:   Gout Interventions:   Drug: PRX-115;   Drug: Placebo Sponsor:   Protalix Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2023 Category: Research Source Type: clinical trials

NLRP3 Inflammasome Activation Among Patients During Acute Gout Flares
Condition:   Gout Arthritis Intervention:   Sponsor:   Centre Hospitalier Saint Joseph Saint Luc de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers With Elevated Uric Acid Levels
Condition:   Gout Interventions:   Drug: PRX-115;   Drug: Placebo Sponsor:   Protalix Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2023 Category: Research Source Type: clinical trials

NLRP3 Inflammasome Activation Among Patients During Acute Gout Flares
Condition:   Gout Arthritis Intervention:   Sponsor:   Centre Hospitalier Saint Joseph Saint Luc de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers With Elevated Uric Acid Levels
Condition:   Gout Interventions:   Drug: PRX-115;   Drug: Placebo Sponsor:   Protalix Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2023 Category: Research Source Type: clinical trials

NLRP3 Inflammasome Activation Among Patients During Acute Gout Flares
Condition:   Gout Arthritis Intervention:   Sponsor:   Centre Hospitalier Saint Joseph Saint Luc de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers With Elevated Uric Acid Levels
Condition:   Gout Interventions:   Drug: PRX-115;   Drug: Placebo Sponsor:   Protalix Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2023 Category: Research Source Type: clinical trials

NLRP3 Inflammasome Activation Among Patients During Acute Gout Flares
Condition:   Gout Arthritis Intervention:   Sponsor:   Centre Hospitalier Saint Joseph Saint Luc de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers With Elevated Uric Acid Levels
Condition:   Gout Interventions:   Drug: PRX-115;   Drug: Placebo Sponsor:   Protalix Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2023 Category: Research Source Type: clinical trials

NLRP3 Inflammasome Activation Among Patients During Acute Gout Flares
Condition:   Gout Arthritis Intervention:   Sponsor:   Centre Hospitalier Saint Joseph Saint Luc de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2023 Category: Research Source Type: clinical trials